Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy

Grant Award Details

Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy
Grant Type: 
Grant Number: 
DISC2P-11946
Project Objective: 
  • The objective is to validate a stem cell-based microphysiological system (MPS) for predicting cardiac toxicity, including modeling drug-drug interactions in polytherapy for the treatment of SARS-CoV-2 in patients with diverse backgrounds
Investigator: 
Name: 
Institution: 
Type: 
PI
Disease Focus: 
COVID-19
Infectious Disease
Human Stem Cell Use: 
iPS Cell
Award Value: 
$224,500
Status: 
Active

Grant Application Details

Application Title: 
  • Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy
Public Abstract: 
Statement of Benefit to California: 
Source URL: https://www.cirm.ca.gov/our-progress/awards/safety-%E2%80%9Cclinical-trial%E2%80%9D-cardiac-liability-covid19-polytherapy